Forge Global (FRGE) 10-Q/A 15 Dec 21 2021 Q2 Quarterly report (amended) Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2021	Dec. 14, 2021
Document Information [Line Items]
Document Type	10-Q/A
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2021
Entity Registrant Name	MOTIVE CAPITAL CORP
Entity Incorporation, State or Country Code	E9
Entity File Number	001-39794
Entity Tax Identification Number	98-1561111
Entity Address, Address Line One	7 World Trade Center, 250 Greenwich St., FL 47
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10007
City Area Code	212
Local Phone Number	651-0200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001827821
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	true
Amendment Description	Amendment No. 1
Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A Ordinary share: $0.0001 par value, and one-third of one redeemable warrant
Trading Symbol	MOTV U
Security Exchange Name	NYSE
Class A Ordinary Shares
Document Information [Line Items]
Title of 12(b) Security	Class A Ordinary Shares included as part of the units
Trading Symbol	MOTV
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		41,400,000
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
Document Information [Line Items]
Title of 12(b) Security	Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
Trading Symbol	MOTV WS
Security Exchange Name	NYSE
Class B Ordinary Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		10,350,000

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (as restated) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 1,006,051	$ 1,674,650
Prepaid expenses	453,076	651,605
Total current assets	1,459,127	2,326,255
Investments held in Trust Account	414,090,409	414,020,525
Total Assets	415,549,536	416,346,780
Current liabilities:
Accounts payable	104,367	961
Accrued expenses	1,218,684	415,560
Total current liabilities	1,323,051	416,521
Deferred underwriting commissions	14,490,000	14,490,000
Derivative liabilities	20,789,520	40,532,280
Total liabilities	36,602,571	55,438,801
Commitments and Contingencies
Class A ordinary shares, $0.0001 par value; 41,400,000 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020	414,000,000	414,000,000
Shareholders' Deficit:
Preference shares, $0.0001 par value 5,000,000 shares authorized none issued and outstanding
Accumulated deficit	(35,054,070)	(53,093,056)
Total shareholders' deficit	(35,053,035)	(53,092,021)
Total Liabilities and Shareholders' Deficit Class A Ordinary Shares Subject to Possible Redemption	415,549,536	416,346,780
Class B Ordinary Shares
Shareholders' Deficit:
Common stock	$ 1,035	$ 1,035

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (as restated) (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Preference shares, par value, (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.0001
Class A Ordinary Shares
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	500,000,000	500,000,000
Temporary equity, shares issued	41,400,000
Class A Ordinary Shares Subject to Redemption
Temporary equity, par value, (per share)	$ 0.0001	$ 0.0001
Temporary equity, shares issued	41,400,000
Temporary equity, shares outstanding	37,394,696
Purchase price, per unit		10
Class A Ordinary Shares Not Subject to Redemption
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	500,000,000	500,000,000
Common shares, shares issued		5,809,203
Common shares, shares outstanding	0
Temporary equity, shares issued	0	0
Temporary equity, shares outstanding	0	0
Class B Ordinary Shares
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	50,000,000	50,000,000
Common shares, shares issued	10,350,000	10,350,000
Common shares, shares outstanding	10,350,000	10,350,000

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
General and administrative expenses	$ 1,501,732	$ 1,773,658
Loss from operations	(1,501,732)	(1,773,658)
Other income (expense)
Change in fair value of derivative liabilities	(1,387,420)	19,742,760
Gain on marketable securities, dividends and interest held in Trust Account	10,325	69,884
Net (loss) income	$ (2,878,827)	$ 18,038,986
Class A Ordinary Shares Subject to Redemption
Other income (expense)
Basis and diluted weighted average shares outstanding	41,400,000	41,400,000
Basic and diluted loss per share	$ (0.06)	$ 0.35
Class B Ordinary Shares Not Subject to Redemption [Member]
Other income (expense)
Basis and diluted weighted average shares outstanding	10,350,000	10,350,000
Basic and diluted loss per share	$ (0.06)	$ 0.35

UNAUDITED CONDENSED CONSOLIDA_2

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Class B Ordinary SharesCommon Stock	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020	$ 1,035	$ (53,093,056)	$ (53,092,021)
Balance at the beginning (in shares) at Dec. 31, 2020	10,350,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		20,917,813	20,917,813
Balance at the end at Mar. 31, 2021	$ 1,035	(32,175,243)	(32,174,208)
Balance at the end (in shares) at Mar. 31, 2021	10,350,000
Balance at the beginning at Dec. 31, 2020	$ 1,035	(53,093,056)	(53,092,021)
Balance at the beginning (in shares) at Dec. 31, 2020	10,350,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)			18,038,986
Balance at the end at Jun. 30, 2021	$ 1,035	(35,054,070)	(35,053,035)
Balance at the end (in shares) at Jun. 30, 2021	10,350,000
Balance at the beginning at Mar. 31, 2021	$ 1,035	(32,175,243)	(32,174,208)
Balance at the beginning (in shares) at Mar. 31, 2021	10,350,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(2,878,827)	(2,878,827)
Balance at the end at Jun. 30, 2021	$ 1,035	$ (35,054,070)	$ (35,053,035)
Balance at the end (in shares) at Jun. 30, 2021	10,350,000

UNAUDITED CONDENSED CONSOLIDA_3

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Cash Flows from Operating Activities:
Net income		$ 18,038,986
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	$ 1,387,420	(19,742,760)
Gain on marketable securities, dividends and interest held in Trust Account	(10,325)	(69,884)
Changes in operating assets and liabilities:
Prepaid expenses		198,529
Accounts payable		103,406
Accrued expenses		803,124
Net cash used in operating activities		(668,599)
Net decrease in cash		(668,599)
Cash - beginning of the period		1,674,650
Cash - end of the period	$ 1,006,051	$ 1,006,051

Description of Organization and

Description of Organization and Business Operations	6 Months Ended
	Jun. 30, 2021
Description of Organization and Business Operations
Description of Organization and Business Operations	Note 1—Description of Organization and Business Operations Motive Capital Corp (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on September 28, 2020 under the name of MCF2 Acquisition Corp. On November 5, 2020 the Company’s name was changed to Motive Capital Corp. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As of June 30, 2021, the Company had not commenced any operations. Our entire activity from September 28, 2020 (inception) through June 30, 2021, was in preparation for an Initial Public Offering, and since our Initial Public Offering, our activity has been limited to the search and due diligence for a prospective initial Business Combination. The Company will not generate any operating revenues until after completion of its Initial Business Combination, at the earliest. The Company generates non-operating gain or loss from the change in fair value of derivative liabilities and non-operating income in the form of interest income, gain on marketable securities, and dividends from the proceeds of its Initial Public Offering and Private Placement described below. The registration statement for the Company’s Initial Public Offering was declared effective on December 10, 2020. On December 15, 2020, the Company consummated the Initial Public Offering of 41,400,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”) which includes the full exercise by the underwriter of its over-allotment option in the amount of 5,400,000 Units, at $10.00 per Unit, generating gross proceeds of $414,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,386,667 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Motive Capital Funds Sponsor, LLC (the “Sponsor”), generating gross proceeds of $11,080,000. Transaction costs amounted to $23,650,262, consisting of $8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees and $880,262 of other offering costs. Following the closing of the Initial Public Offering on December 15, 2020, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earliest of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially anticipated to be $10.00 per Public Share), including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to certain limitations as described in the prospectus. The per-share amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust Account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares. The Company will have until December 15, 2022 to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	6 Months Ended
	Jun. 30, 2021
Restatement of Previously Issued Financial Statements
Restatement of Previously Issued Financial Statements	Note 2 – Restatement of Previously Issued Financial Statements After preparation of the Company’s unaudited condensed financial statements for the quarterly period ended September 30, 2021, the Company concluded it should revise its previously issued financial statements to classify all Class A ordinary shares subject to redemption in temporary equity. Subsequent to the filing of the 10-Q for the quarterly period ending June 30, 2021, the Company concluded it should restate its prior-filed financial statements to classify all Class A ordinary shares subject to possible redemption in temporary equity. Subsequent to the filing of the 10-Q for the quarterly period ending September 30, 2021, the Company concluded it should restate its prior-filed financial statements to classify all Class A ordinary shares subject to possible redemption in temporary equity. In accordance with ASC 480-10-S99, redemption provisions not solely within the control of the Company require shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Class A ordinary shares in permanent equity. Although the Company did not specify a maximum redemption threshold, its charter currently provides that the Company will not redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. Effective with its September 30, 2021 financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. In connection with the change in presentation for the Class A ordinary shares subject to possible redemption, the Company revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation differs from the previously presented method of earnings per share, which was similar to the two-class method. In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company evaluated the corrections and has determined that the related impact was material to the previously filed financial statements that contained the error, reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 13, 2021. Therefore, the Company, in consultation with its Audit Committee, concluded that the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 13, 2021 should be restated to present all Class A ordinary shares subject to possible redemption as temporary equity, restate earnings per share and to recognize accretion from the initial book value to redemption value at the time of its Initial Public Offering. The previously presented unaudited interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 13, 2021, should no longer be relied upon. The restatement does not have an impact on the Company’s cash position and cash held in the Trust Account. The table below presents the effect of the financial statement adjustments related to the restatement discussed above to the Company’s previously reported balance sheet as of June 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2021 (unaudited) As Previously Reported Adjustment As Restated Total assets ​ $ 415,549,535 ​ $ 1 ​ $ 415,549,536 Total liabilities ​ ​ 36,602,571 ​ ​ — ​ ​ 36,602,571 Class A ordinary shares subject to redemption ​ 373,946,960 ​ 40,053,040 ​ 414,000,000 Preference shares, par value $0.0001 ​ — ​ — ​ — Class A ordinary shares, par value $0.0001 ​ 400 ​ (400) ​ — Class B ordinary shares, par value $0.0001 ​ 1,035 ​ — ​ 1,035 Additional paid-in capital ​ — ​ — ​ — Accumulated deficit ​ 4,998,569 ​ (40,052,639) ​ (35,054,070) Total shareholders’ equity (deficit) ​ 5,000,004 ​ (40,053,039) ​ (35,053,035) Total liabilities, Class A ordinary shares subject to redemption and shareholders’ equity (deficit) $ 415,549,535 $ 1 $ 415,549,536 Class A ordinary shares subject to redemption ​ ​ 37,394,696 ​ ​ 4,005,304 ​ ​ 41,400,000 Class A ordinary shares ​ 4,005,304 ​ (4,005,304) ​ — ​ The Company’s statement of changes in shareholders’ deficit has been restated to reflect the changes to the impacted shareholders’ equity accounts described above. The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Form 10-Q: Six Months Ended June 30, 2021 (unaudited) ​ As Previously Reported Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: ​ ​ ​ ​ Change in value of Class A ordinary shares subject to possible redemption $ 18,038,990 $ (18,038,990) $ — ​ The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per share is presented below for the three and six months ended June 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ EPS for Class A ordinary shares ​ As Previously Reported Adjustment As Restated Form 10-Q (June 30,2021) – three months ended June 30, 2021 (unaudited) ​ ​ ​ Net loss $ (2,878,827) $ — $ (2,878,827) Weighted average shares outstanding ​ 41,400,000 ​ — ​ 41,400,000 Basic and diluted loss per share $ — $ (0.06) $ (0.06) Form 10-Q (June 30,2021) – six months ended June 30, 2021 (unaudited) ​ ​ ​ Net income $ 18,038,986 $ — $ 18,038,986 Weighted average shares outstanding ​ 41,400,000 ​ — ​ 41,400,000 Basic and diluted earnings per share $ — $ 0.35 $ 0.35 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ EPS for Class B ordinary shares ​ ​ As Previously Reported ​ Adjustment ​ As Restated Form 10-Q (June 30, 2021) - three months ended June 30, 2021 (unaudited) ​ ​ ​ Net loss ​ $ (2,878,827) ​ $ — ​ $ (2,878,827) Weighted average shares outstanding ​ ​ 10,350,000 ​ ​ — ​ ​ 10,350,000 Basic and diluted loss per share ​ $ (0.28) ​ $ 0.22 ​ $ (0.06) Form 10-Q (June 30, 2021) - six months ended June 30, 2021 (unaudited) ​ ​ ​ Net income ​ $ 18,038,986 ​ $ — ​ $ 18,038,986 Weighted average shares outstanding ​ 10,350,000 ​ ​ — ​ ​ 10,350,000 Basic and diluted earnings per share ​ $ 1.74 ​ $ (1.39) ​ $ 0.35 ​ ​ Class A Ordinary Shares Subject to Possible Redemption The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. As of June 30, 2021, there were 41,400,000 Class A ordinary shares outstanding, all of which were subject to possible redemption. The Class A ordinary shares issued in the Initial Public Offering and issued as part of the Over-Allotment Units were recognized in Class A ordinary shares subject to possible redemption as follows: ​ ​ ​ ​ ​ Gross Proceeds $ 414,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (19,458,000) Class A ordinary shares issuance costs ​ (22,524,192) Plus: ​ Accretion of carrying value to redemption value ​ 41,982,192 Class A ordinary shares subject to possible redemption ​ $ 414,000,000 ​ Going Concern In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 15, 2022 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 15, 2022.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies (as restated)	6 Months Ended
	Jun. 30, 2021
Basis of Presentation and Summary of Significant Accounting Policies (as restated)
Basis of Presentation and Summary of Significant Accounting Policies (as restated)	Note 3—Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or any future period. The accompanying condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K/A filed by the Company with the SEC on December 15, 2021. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020 there were no cash equivalents held in the Trust Account. Investments Held in Trust Account The Company’s portfolio of investments held in trust is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these investments are included in gain on marketable securities, dividends and interest held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000 and investments held in Trust Account. As of June 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of June 30, 2021 and December 31, 2020, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of investments held in the Trust Account is comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in money market funds that invest in U.S. government securities, or a combination thereof. The fair value for trading securities is determined using quoted market prices in active markets. Prior to the Public Warrants being separately traded in an active market, the fair value of the Public Warrants issued in connection with the Public Offering and the Private Placement Warrants were measured using a binomial lattice model in a risk-neutral framework. The fair value of the forward purchase agreement is based on the fair value of the Company’s publicly traded Units on each valuation date, less the present value of the contractually stipulated forward price of $10.00. Beginning in February 2021, the fair value of the Public Warrants are determined based on the listed price in an active market for such warrants and the fair value of the Private Placement Warrants is estimated to be approximately equal to that of the Public Warrants given the low likelihood of the Company’s ordinary share price exceeding $18.00 by the start of the exercise period. Derivative liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Public Warrants and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the Public Warrants issued in connection with the Initial Public Offering were estimated using a binomial lattice model in a risk-neutral framework. The fair value of the Public Warrants as of June 30, 2021 is based on observable listed prices for such warrants. The fair value of the Private Placement Warrants as of June 30, 2021 is based on the value of the Public Warrants given the low likelihood of the Company’s ordinary share price exceeding $18.00 by the start of the exercise period. The fair value of the forward purchase agreement is based on the fair value of the Company’s publicly traded Units on each valuation date, less the present value of the contractually stipulated forward price of $10.00. The determination of the fair value of derivative liabilities may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Offering Costs Associated with the Initial Public Offering Offering costs consist of legal, accounting, underwriting fees and other costs incurred that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative liabilities are expensed as incurred, presented as non-operating expenses in the statements of operations. Offering costs associated with the Public Shares were charged to shareholders’ equity upon completion of the Initial Public Offering. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary share subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 41,400,000 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional paid-in capital and accumulated deficit. Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Income Taxes FASB ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the condensed financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (loss) per Ordinary Share The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 21,186,667, of the Company’s Class A ordinary shares in the calculation of diluted net income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and six months ended June 30, 2021. The remeasurement of the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. Recent Adopted Accounting Standards In August 2020, the Financial Accounting Standards Board issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Recent Issued Accounting Standards The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2021
Initial Public Offering
Initial Public Offering	Note 4—Initial Public Offering Pursuant to the Initial Public Offering, the Company sold 41,400,000 Units, which includes a full exercise by the underwriters of their over-allotment option in the amount of 5,400,000 Units, at a purchase price of $10.00 per Unit. Each Unit consist of one Class A ordinary share and one

Private Placement

Private Placement	6 Months Ended
	Jun. 30, 2021
Private Placement
Private Placement	Note 5—Private Placement Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,386,667 Private Placement Warrants at a price of $ 1.50 per Private Placement Warrant, for an aggregate purchase price of $11,080,000, in a private placement. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2021
Related Party Transactions
Related Party Transactions	Note 6—Related Party Transactions Founder Shares On October 2, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 11,500,000 Class B ordinary shares (the “Founder Shares”). On November 24, 2020, the Sponsor surrendered 2,875,000 Founder Shares, which the Company canceled. On November 24 and December 8, 2020, the Sponsor transferred 30,000 founder shares to each of the independent directors. On December 10, 2020, the Company issued a dividend of 1,725,000 Class B ordinary shares, resulting in 10,350,000 Founder Shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share cancellation. The Founder Shares include an aggregate of up to 1,350,000 shares The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2021 and December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans. Promissory Note Related Party On October 1, 2020, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) December 31, 2020 and (ii) the completion of the Initial Public Offering. The Company borrowed an aggregate of $130,492 under the Promissory Note. The Promissory Note matured on the closing date of the Initial Public Offering and the outstanding balance under the Promissory Note of $130,492 was repaid in full on December 16, 2020. Subsequent to the repayment, the facility was no longer available to the Company. Administrative Support Agreement The Company entered into an agreement, commencing on December 15, 2020 the effective date of the Initial Public Offering through the earlier of the consummation of a Business Combination or the Company’s liquidation, to pay the Sponsor or its affiliate a monthly fee of up to $10,000 for office space, utilities, secretarial and administrative services. As of June 30, 2021, the Company did not incur any fees for the administrative support. The Sponsor has waived such fees and such fees will not be payable until the Sponsor determines that such fees should be paid.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies
Commitments and Contingencies	Note 7—Commitments and Contingencies Registration Rights Pursuant to a registration and shareholders rights agreement entered into on December 10, 2020, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans) will have registration rights to require the Company to register a sale of any of our securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 14,490,000 Over-Allotment Units to cover over-allotments, if any, at the Initial Public Offering price less underwriting discounts and commissions. The underwriters were entitled to underwriting discounts of $0.35 per unit, or approximately $14,490,000 in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Derivative Liabilities

Derivative Liabilities	6 Months Ended
	Jun. 30, 2021
Derivative Liabilities
Derivative Liabilities	Note 8— Derivative Liabilities As of June 30, 2021 and December 31, 2020, the Company had outstanding 13,800,000 Public Warrants, 7,386,667 Private Placement Warrants and a forward purchase agreement, covering up to 14,000,000 forward purchase units. Warrants Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) one year from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable, and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 . ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days prior written notice of redemption to each warrant holder; and if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30 - trading day period ending three business days before the Company sends the notice of redemption to the warrant holders ● (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like). If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00 ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A ordinary shares; ● if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like); and ● if the Reference Value is less than $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations, and the like) the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities, excluding the forward purchase securities, for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $10.00 and $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Forward Purchase Agreement The Company entered into a forward purchase agreement with affiliates of the Company’s sponsor pursuant to which the affiliates intend to purchase an aggregate of 14,000,000 of forward purchase units, consisting of one Class A ordinary share (the “forward purchase shares”) and one-third of one redeemable warrant to purchase one Class A ordinary share (the “forward purchase warrant”), for a purchase price of $10.00 per forward purchase unit, or an aggregate amount of $140,000,000, in a private placement to close concurrently with the closing of a Business Combination. The affiliates’ commitment under the forward purchase agreement is subject to, among other conditions, investment committee approval and sufficiency of capital to purchase. The obligations under the forward purchase agreements will not depend on whether any Class A ordinary shares are redeemed by the Public Shareholders. The forward purchase shares will be identical to the Class A ordinary share included in the Units being sold in the Initial Public Offering, except that they will be subject to transfer restrictions and registration rights. The forward purchase warrants will have the same terms as the public warrants. The affiliates’ commitment under the forward purchase agreement is subject to, among other conditions, investment committee approval and sufficiency of capital to purchase.

Shareholders' Deficit

Shareholders' Deficit	6 Months Ended
	Jun. 30, 2021
Shareholders' Deficit
Shareholders' Equity	Note 9—Shareholders’ Deficit Preference Shares Class A Ordinary Shares outstanding 41,400,000 Class B Ordinary Shares Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2021
Fair Value Measurements
Fair Value Measurements	Note 10—Fair Value Measurements A reconciliation of the beginning and ending balances of the derivative liabilities is summarized below: ​ ​ ​ ​ ​ Beginning of period ​ Warrant Liabilities - Public ​ $ 21,390,000 Warrant Liabilities - Private ​ 11,449,330 Forward Purchase agreement ​ 7,692,950 Beginning of period total ​ $ 40,532,280 Change in fair value of warrant liabilities – Public ​ (8,238,600) Change in fair value of warrant liabilities – Private ​ (4,409,840) Change in fair value of forward purchase agreement ​ (7,094,320) End of period ​ $ 20,789,520 ​ The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020, by level within the fair value hierarchy: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measured as of June 30, 2021 ​ Level 1 Level 2 Level 3 Total Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account ​ $ 414,090,409 ​ $ — ​ $ — ​ $ 414,090,409 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative liabilities - public warrants ​ ​ 13,151,400 ​ ​ — ​ ​ — ​ ​ 13,151,400 Derivative liabilities - private placement warrants ​ ​ — ​ ​ 7,039,490 ​ ​ — ​ ​ 7,039,490 Derivative liabilities - forward purchase agreement ​ ​ — ​ ​ — ​ ​ 598,630 ​ ​ 598,630 Total liabilities ​ $ 13,151,400 ​ $ 7,039,490 ​ $ 598,630 ​ $ 20,789,520 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measured as of December 31, 2020 ​ Level 1 Level 2 Level 3 Total Assets: ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account $ 414,020,525 ​ $ — ​ $ — ​ $ 414,020,525 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative liabilities - public warrants ​ ​ — ​ ​ — ​ ​ 21,390,000 ​ ​ 21,390,000 Derivative liabilities - private placement warrants ​ — ​ ​ — ​ 11,449,330 ​ ​ 11,449,330 Derivative liabilities - forward purchase agreement ​ ​ — ​ ​ — ​ ​ 7,692,950 ​ ​ 7,692,950 Total liabilities $ — ​ $ — ​ $ 40,532,280 ​ $ 40,532,280 ​ Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement and the estimated fair value of the Private Placement Warrants transferred from a Level 3 measurement to a Level 2 fair value measurement, as a result of the Public Warrants being listed in an active market in February 2021. Prior to the Public Warrants being separately traded in an active market, the fair value of the Public Warrants issued in connection with the Public Offering and the Private Placement Warrants were measured using a binomial lattice model in a risk-neutral framework. The fair value of the forward purchase agreement is based on the fair value of the Company’s publicly traded Units on each valuation date, less the present value of the contractually stipulated forward price of $10.00. Beginning in February 2021, the fair value of the Public Warrants are determined based on the listed price in an active market for such warrants and the fair value of the Private Placement Warrants is estimated to be approximately equal to that of the Public Warrants given the low likelihood of the Company’s ordinary share price exceeding $18.00 by the start of the exercise period. For the three and six months ended June 30, 2021, the Company recognized a non-operating loss and gain in the unaudited condensed statements of operations resulting from an increase and decrease in the fair value of derivative liabilities of approximately $1.4 million and $19.7 million, respectively, which is presented as change in fair value of derivative liabilities in the accompanying unaudited condensed statements of operations. The estimated fair value of the Private Placement Warrants, Public Warrants and Forward Purchase Agreement, as of December 31, 2020 was determined using Level 3 inputs. The Company estimates the volatility of its ordinary share warrants based on implied volatility from historical volatility of select peer company’s ordinary shares that matches the expected remaining life of the warrants. The following table provides quantitative information regarding Level 3 fair value measurements inputs as of each measurement date: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of ​ As of ​ As of ​ June 30, 2021 March 31, 2021 December 31, 2020 ​ Share price, used in warrant valuations ​ n/a ​ ​ n/a ​ $ 10.02 ​ Unit price, used in forward valuation ​ $ 10.04 ​ $ 10.05 ​ $ 10.54 ​ Exercise price, warrants ​ ​ n/a ​ ​ n/a ​ $ 11.50 ​ Exercise price, forward ​ $ 10.00 ​ $ 10.00 ​ $ 10.00 ​ Term (in years), used in warrant valuations ​ ​ n/a ​ ​ n/a ​ ​ 6.00 ​ Term (in years), used in forward valuation ​ ​ 0.46 ​ ​ 0.71 ​ ​ 0.96 ​ Volatility ​ ​ n/a ​ ​ n/a ​ ​ 21.00 % Risk-free interest rate, used in warrant valuations ​ ​ n/a ​ ​ n/a ​ ​ 0.50 % Risk-free interest rate, used in forward valuation ​ ​ 0.06 % ​ 0.06 % ​ 0.10 % Expected dividends ​ ​ n/a ​ ​ n/a ​ ​ n/a ​ ​ The change in the fair value of the derivative warrant liabilities, classified as Level 3, for the three and six months ended June 30, 2021 is summarized as follows: ​ ​ ​ ​ ​ Level 3 derivative liabilities at December 31, 2020 $ 40,532,280 Transfers from Level 3 ​ ​ (32,839,330) Change in fair value ​ ​ (6,935,120) Level 3 derivative liabilities at March 31, 2021 ​ $ 757,830 Change in fair value ​ ​ (159,200) Level 3 derivative liabilities at June 30, 2021 ​ $ 598,630 ​

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events
Subsequent Events	Note 11—Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date these unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. Proposed Business Combination On September 13, 2021, the Company entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among the Company, FGI Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”), and Forge Global, Inc., a Delaware corporation (“Forge”). The Merger Agreement provides for, among other things, the following transactions: (i) the Company will change its jurisdiction of incorporation by transferring by way of continuation from the Cayman Islands and domesticating as a corporation incorporated under the laws of the State of Delaware (the “Domestication”), and, in connection with the Domestication, (A) each outstanding Class A ordinary share of the Company will convert automatically into one share of common stock, par value $0.0001 per share (the “Domesticated Company Common Stock”), (B) each outstanding Class B ordinary share of the Company will convert automatically into one share of Domesticated Company Common Stock, (C) each outstanding warrant to purchase one Class A ordinary share at an exercise price of $11.50 that was included in the Units sold as part of Company’s initial public offering (a “Public Warrant”) will convert automatically, on a one-for-one basis, into a warrant to acquire one share of Domesticated Company Common Stock (“Domesticated Company Public Warrant”), (D) each outstanding Private Placement Warrant issued to the Sponsor will convert automatically, on a one-for-one basis, into a warrant to acquire one share of Domesticated Company Common Stock and (E) each outstanding Unit of the Company, to the extent not already split by the holder thereof, convert automatically, into one share of Domesticated Company Common Stock and one Subject to the terms and conditions set forth in the Merger Agreement, in consideration of the Merger, each outstanding share of Forge’s capital stock (excluding shares owned by the Company or by Forge as treasury stock or dissenting shares) (i) if vested, will be canceled and converted into the right to receive either cash or Domesticated Company Common Stock, or a combination thereof, equal to the Per-Share Merger Consideration, which mix of cash and stock shall correspond to that elected by each of holder of Forge vested shares; provided, that in no event shall a holder of Forge vested shares be permitted to elect greater than fifteen percent (15%) cash and in no event will the aggregate amount of cash payable to all holders of vested Forge shares exceed $100 million and (ii) if unvested, will be canceled and converted into the right to receive a number of shares of unvested Domesticated Company Common Stock (subject to the same terms and conditions, including with respect to vesting, as the unvested share of Forge’s capital stock) equal to (A) the Securities Merger Consideration multiplied by (B) the Exchange Ratio. The total consideration paid to holders of Forge’s outstanding equity securities will include shares of Domesticated Company Common Stock and options and warrants to acquire shares of Domesticated Company Common Stock, having an aggregate value equal to $1.5 billion, less the amount of any cash consideration payable to holders of vested Forge shares, consisting of (assuming the maximum amount of cash consideration) an aggregate of 140 million newly issued shares of Domesticated Company Common Stock and options and warrants to acquire shares of Domesticated Company Common Stock, in each case, with a deemed value of $10.00 per share solely for purposes of determining the aggregate number of shares payable to holders of Forge capital stock. As a result, at the closing of the Merger and the other transactions contemplated by the Merger Agreement (the “Closing”), (i) each outstanding option to purchase Forge capital stock, whether vested or unvested, will be assumed and converted into an option with respect to a number of shares of Domesticated Company Common Stock in the manner set forth in the Merger Agreement and (ii) each outstanding warrant to purchase Forge capital stock, whether or not exercisable, will be assumed and converted into a warrant with respect to a number of shares of Domesticated Company Common Stock in the manner set forth in the Merger Agreement. Concurrent with the execution of the Merger Agreement, the Company entered into that certain Sponsor Support Agreement (the “Sponsor Agreement”) with the Sponsor, Forge and other holders of Company’s Class B ordinary shares pursuant to which the Sponsor and such holders of Class B ordinary shares have agreed to (i) vote all shares of the Company they own in favor of the transactions contemplated by the Merger Agreement, (ii) waive certain anti-dilution rights with respect to their Class B ordinary shares, and (iii) agree to certain lock-up provisions. Concurrent with the execution of the Merger Agreement, the Company entered into that certain Stockholder Support Agreement (the “Stockholder Support Agreement”) with Forge and certain Forge shareholders (the “Supporting Shareholders”) pursuant to which the Supporting Shareholders agreed to vote in favor of the Merger and the transactions contemplated by the Merger Agreement. Concurrent with the execution of the Merger Agreement, the Company amended and restated that certain Forward Purchase Agreement, dated as of November 24, 2020, by and between the Company, the Sponsor and certain affiliates of the Sponsor (the “Purchasers”; and such agreement the “A&R Forward Purchase Agreement”). Pursuant to the A&R Forward Purchase Agreement, subject to the fulfillment of certain conditions, the Purchasers will collectively purchase concurrently with the Closing, at a per-unit price of $10.00, 5,000,000 Forward Purchase Units, each composed of one share of Domesticated Company Common Stock and one-third of one Domesticated Company Public Warrant (a “Forward Purchase Unit”) , and up to an additional 9,000,000 Forward Purchase Units to the extent of redemptions on a dollar-for-dollar basis by Company shareholders of all or a portion of their Class A ordinary shares. For the avoidance of doubt, regardless of the extent of such redemptions, the Purchasers will in no event be required to purchase more than an aggregate amount of 14,000,000 Forward Purchase Units. The Merger Agreement contemplates that, at the Closing, the Company, the Sponsor, and certain Company and Forge stockholders will enter into a registration rights agreement pursuant to which, among other things, the Company will agree to undertake certain customary registration obligations in accordance with the Securities Act and certain subsequent related transactions and obligations. Pursuant to the Registration Rights Agreement, the Company will agree that, within 30 calendar days after the Closing, the Company will file with the SEC a registration statement registering the resale of certain securities held by or issuable to the stockholders party thereto, and use its reasonable best efforts to have such registration statement declared effective by the SEC as soon as practicable thereafter. Concurrent with the execution of the Merger Agreement, the Company entered into subscription agreements (each, a “Subscription Agreement”) with certain investors (the “PIPE Investors”) pursuant to which, among other things, the PIPE Investors have agreed to subscribe for and purchase, and the Company has agreed to issue and sell to the PIPE Investors an aggregate of 6.85 million shares of Domesticated Company Common Stock, at a per share price of $10.00 for an aggregate purchase price of $68,500,000, concurrent with the Closing, on the terms and subject to the conditions set forth therein (the “PIPE Financing”). The Subscription Agreement contains customary representations and warranties of the Company, on the one hand, and each PIPE Investor, on the other hand, and customary conditions to closing, including the consummation of the transactions contemplated by the Merger Agreement. Each Subscription Agreement provides that the Company will grant the PIPE Investors certain customary registration rights.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (as restated) (Policies)	6 Months Ended
	Jun. 30, 2021
Basis of Presentation and Summary of Significant Accounting Policies (as restated)
Basis of Presentation	Basis of Presentation The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or any future period. The accompanying condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K/A filed by the Company with the SEC on December 15, 2021.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2021 and December 31, 2020 there were no cash equivalents held in the Trust Account.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments held in trust is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these investments are included in gain on marketable securities, dividends and interest held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000 and investments held in Trust Account. As of June 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of June 30, 2021 and December 31, 2020, the carrying values of cash, prepaid expenses, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of investments held in the Trust Account is comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in money market funds that invest in U.S. government securities, or a combination thereof. The fair value for trading securities is determined using quoted market prices in active markets. Prior to the Public Warrants being separately traded in an active market, the fair value of the Public Warrants issued in connection with the Public Offering and the Private Placement Warrants were measured using a binomial lattice model in a risk-neutral framework. The fair value of the forward purchase agreement is based on the fair value of the Company’s publicly traded Units on each valuation date, less the present value of the contractually stipulated forward price of $10.00. Beginning in February 2021, the fair value of the Public Warrants are determined based on the listed price in an active market for such warrants and the fair value of the Private Placement Warrants is estimated to be approximately equal to that of the Public Warrants given the low likelihood of the Company’s ordinary share price exceeding $18.00 by the start of the exercise period.
Derivative liabilities	Derivative liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Public Warrants and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The initial fair value of the Public Warrants issued in connection with the Initial Public Offering were estimated using a binomial lattice model in a risk-neutral framework. The fair value of the Public Warrants as of June 30, 2021 is based on observable listed prices for such warrants. The fair value of the Private Placement Warrants as of June 30, 2021 is based on the value of the Public Warrants given the low likelihood of the Company’s ordinary share price exceeding $18.00 by the start of the exercise period. The fair value of the forward purchase agreement is based on the fair value of the Company’s publicly traded Units on each valuation date, less the present value of the contractually stipulated forward price of $10.00. The determination of the fair value of derivative liabilities may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consist of legal, accounting, underwriting fees and other costs incurred that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative liabilities are expensed as incurred, presented as non-operating expenses in the statements of operations. Offering costs associated with the Public Shares were charged to shareholders’ equity upon completion of the Initial Public Offering.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary share subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 41,400,000 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional paid-in capital and accumulated deficit. Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security.
Income Taxes	Income Taxes FASB ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the condensed financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (loss) per Ordinary Share	Net Income (loss) per Ordinary Share The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 21,186,667, of the Company’s Class A ordinary shares in the calculation of diluted net income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and six months ended June 30, 2021. The remeasurement of the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value.
Recent Adopted and Issued Accounting Standards	Recent Adopted Accounting Standards In August 2020, the Financial Accounting Standards Board issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Recent Issued Accounting Standards The Company’s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	6 Months Ended
	Jun. 30, 2021
Restatement of Previously Issued Financial Statements
Schedule of impact of the restatements on the Company's previously issued financial statements	The table below presents the effect of the financial statement adjustments related to the restatement discussed above to the Company’s previously reported balance sheet as of June 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2021 (unaudited) As Previously Reported Adjustment As Restated Total assets ​ $ 415,549,535 ​ $ 1 ​ $ 415,549,536 Total liabilities ​ ​ 36,602,571 ​ ​ — ​ ​ 36,602,571 Class A ordinary shares subject to redemption ​ 373,946,960 ​ 40,053,040 ​ 414,000,000 Preference shares, par value $0.0001 ​ — ​ — ​ — Class A ordinary shares, par value $0.0001 ​ 400 ​ (400) ​ — Class B ordinary shares, par value $0.0001 ​ 1,035 ​ — ​ 1,035 Additional paid-in capital ​ — ​ — ​ — Accumulated deficit ​ 4,998,569 ​ (40,052,639) ​ (35,054,070) Total shareholders’ equity (deficit) ​ 5,000,004 ​ (40,053,039) ​ (35,053,035) Total liabilities, Class A ordinary shares subject to redemption and shareholders’ equity (deficit) $ 415,549,535 $ 1 $ 415,549,536 Class A ordinary shares subject to redemption ​ ​ 37,394,696 ​ ​ 4,005,304 ​ ​ 41,400,000 Class A ordinary shares ​ 4,005,304 ​ (4,005,304) ​ — ​ The Company’s statement of changes in shareholders’ deficit has been restated to reflect the changes to the impacted shareholders’ equity accounts described above. The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Form 10-Q: Six Months Ended June 30, 2021 (unaudited) ​ As Previously Reported Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: ​ ​ ​ ​ Change in value of Class A ordinary shares subject to possible redemption $ 18,038,990 $ (18,038,990) $ — ​ The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per share is presented below for the three and six months ended June 30, 2021: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ EPS for Class A ordinary shares ​ As Previously Reported Adjustment As Restated Form 10-Q (June 30,2021) – three months ended June 30, 2021 (unaudited) ​ ​ ​ Net loss $ (2,878,827) $ — $ (2,878,827) Weighted average shares outstanding ​ 41,400,000 ​ — ​ 41,400,000 Basic and diluted loss per share $ — $ (0.06) $ (0.06) Form 10-Q (June 30,2021) – six months ended June 30, 2021 (unaudited) ​ ​ ​ Net income $ 18,038,986 $ — $ 18,038,986 Weighted average shares outstanding ​ 41,400,000 ​ — ​ 41,400,000 Basic and diluted earnings per share $ — $ 0.35 $ 0.35 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ EPS for Class B ordinary shares ​ ​ As Previously Reported ​ Adjustment ​ As Restated Form 10-Q (June 30, 2021) - three months ended June 30, 2021 (unaudited) ​ ​ ​ Net loss ​ $ (2,878,827) ​ $ — ​ $ (2,878,827) Weighted average shares outstanding ​ ​ 10,350,000 ​ ​ — ​ ​ 10,350,000 Basic and diluted loss per share ​ $ (0.28) ​ $ 0.22 ​ $ (0.06) Form 10-Q (June 30, 2021) - six months ended June 30, 2021 (unaudited) ​ ​ ​ Net income ​ $ 18,038,986 ​ $ — ​ $ 18,038,986 Weighted average shares outstanding ​ 10,350,000 ​ ​ — ​ ​ 10,350,000 Basic and diluted earnings per share ​ $ 1.74 ​ $ (1.39) ​ $ 0.35
Schedule of Class A ordinary shares subject to possible redemption reflected on the condensed balance sheet	​ ​ ​ ​ ​ Gross Proceeds $ 414,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (19,458,000) Class A ordinary shares issuance costs ​ (22,524,192) Plus: ​ Accretion of carrying value to redemption value ​ 41,982,192 Class A ordinary shares subject to possible redemption ​ $ 414,000,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2021
Fair Value Measurements
Schedule of company's assets and liabilities that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measured as of June 30, 2021 ​ Level 1 Level 2 Level 3 Total Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account ​ $ 414,090,409 ​ $ — ​ $ — ​ $ 414,090,409 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative liabilities - public warrants ​ ​ 13,151,400 ​ ​ — ​ ​ — ​ ​ 13,151,400 Derivative liabilities - private placement warrants ​ ​ — ​ ​ 7,039,490 ​ ​ — ​ ​ 7,039,490 Derivative liabilities - forward purchase agreement ​ ​ — ​ ​ — ​ ​ 598,630 ​ ​ 598,630 Total liabilities ​ $ 13,151,400 ​ $ 7,039,490 ​ $ 598,630 ​ $ 20,789,520 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Fair Value Measured as of December 31, 2020 ​ Level 1 Level 2 Level 3 Total Assets: ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account $ 414,020,525 ​ $ — ​ $ — ​ $ 414,020,525 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Derivative liabilities - public warrants ​ ​ — ​ ​ — ​ ​ 21,390,000 ​ ​ 21,390,000 Derivative liabilities - private placement warrants ​ — ​ ​ — ​ 11,449,330 ​ ​ 11,449,330 Derivative liabilities - forward purchase agreement ​ ​ — ​ ​ — ​ ​ 7,692,950 ​ ​ 7,692,950 Total liabilities $ — ​ $ — ​ $ 40,532,280 ​ $ 40,532,280
Schedule of quantitative information regarding Level 3 fair value measurements inputs	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of ​ As of ​ As of ​ June 30, 2021 March 31, 2021 December 31, 2020 ​ Share price, used in warrant valuations ​ n/a ​ ​ n/a ​ $ 10.02 ​ Unit price, used in forward valuation ​ $ 10.04 ​ $ 10.05 ​ $ 10.54 ​ Exercise price, warrants ​ ​ n/a ​ ​ n/a ​ $ 11.50 ​ Exercise price, forward ​ $ 10.00 ​ $ 10.00 ​ $ 10.00 ​ Term (in years), used in warrant valuations ​ ​ n/a ​ ​ n/a ​ ​ 6.00 ​ Term (in years), used in forward valuation ​ ​ 0.46 ​ ​ 0.71 ​ ​ 0.96 ​ Volatility ​ ​ n/a ​ ​ n/a ​ ​ 21.00 % Risk-free interest rate, used in warrant valuations ​ ​ n/a ​ ​ n/a ​ ​ 0.50 % Risk-free interest rate, used in forward valuation ​ ​ 0.06 % ​ 0.06 % ​ 0.10 % Expected dividends ​ ​ n/a ​ ​ n/a ​ ​ n/a ​
Schedule of change in the fair value of the derivative liabilities	​ ​ ​ ​ ​ Beginning of period ​ Warrant Liabilities - Public ​ $ 21,390,000 Warrant Liabilities - Private ​ 11,449,330 Forward Purchase agreement ​ 7,692,950 Beginning of period total ​ $ 40,532,280 Change in fair value of warrant liabilities – Public ​ (8,238,600) Change in fair value of warrant liabilities – Private ​ (4,409,840) Change in fair value of forward purchase agreement ​ (7,094,320) End of period ​ $ 20,789,520 ​ ​ ​ ​ ​ Level 3 derivative liabilities at December 31, 2020 $ 40,532,280 Transfers from Level 3 ​ ​ (32,839,330) Change in fair value ​ ​ (6,935,120) Level 3 derivative liabilities at March 31, 2021 ​ $ 757,830 Change in fair value ​ ​ (159,200) Level 3 derivative liabilities at June 30, 2021 ​ $ 598,630

Description of Organization a_2

Description of Organization and Business Operations (Details)	Dec. 15, 2020USD ($)$ / sharesshares	Jun. 30, 2021USD ($)item$ / sharesshares	Dec. 31, 2020USD ($)shares
Subsidiary, Sale of Stock [Line Items]
Transaction Costs	$ 23,650,262
Underwriting fees	8,280,000
Deferred underwriting fee payable	14,490,000
Other offering costs	$ 880,262
Cash		$ 1,006,051	$ 1,674,650
Condition for future business combination number of businesses minimum | item		1
Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account.		80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination.		50.00%
Minimum net tangible assets upon consummation of business combination		$ 5,000,001
Redemption limit percentage without prior consent		15
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)		100.00%
Maximum Allowed Dissolution Expenses		$ 100,000
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares		7,386,667	7,386,667
Initial Public Offering.
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	41,400,000
Purchase price, per unit | $ / shares	$ 10
Proceeds from issuance initial public offering	$ 414,000,000
Initial Public Offering. | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares		21,186,667
Initial Public Offering. | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares		13,800,000	13,800,000
Private Placement. | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares	7,386,667	7,386,667
Price of warrant | $ / shares	$ 1.50	$ 11,080,000
Proceeds from sale of Private Placement Warrants	$ 11,080,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	5,400,000
Purchase price, per unit | $ / shares	$ 10
Over-allotment option | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares		1.50

Description of Organization a_3

Description of Organization and Business Operations - Proposed Business Combination (Details) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Par value	$ 0.0001
Class A Ordinary Shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Par value	0.0001	$ 0.0001
Class B Ordinary Shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Par value	0.0001	$ 0.0001
Subscription Agreement | PIPE Investors
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Share price	$ 10

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Balance sheet (Details) - USD ($)	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Dec. 10, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total assets	$ 415,549,536		$ 416,346,780
Total liabilities	36,602,571		55,438,801
Class A ordinary shares subject to redemption	414,000,000		414,000,000
Preference shares, par value $0.0001
Accumulated deficit	(35,054,070)		(53,093,056)
Total shareholders' equity (deficit)	(35,053,035)	$ (32,174,208)	(53,092,021)
Total liabilities, Class A ordinary shares subject to redemption and shareholders' equity (deficit)	$ 415,549,536		$ 416,346,780
Preference shares, par value, (per share)	$ 0.0001		$ 0.0001
Common stock, par value (in dollars per share)	0.0001
Class A Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock, par value (in dollars per share)	$ 0.0001		$ 0.0001
Class A Ordinary Shares Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to redemption	37,394,696
Class B Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares	$ 1,035		$ 1,035
Common stock, shares outstanding (in shares)	10,350,000		10,350,000	1,725,000
Common stock, par value (in dollars per share)	$ 0.0001		$ 0.0001
As Restated
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Minimum net intangible assets required to redemption of common stock	$ 5,000,001
Total assets	415,549,536
Total liabilities	36,602,571
Class A ordinary shares subject to redemption	414,000,000
Accumulated deficit	(35,054,070)
Total shareholders' equity (deficit)	(35,053,035)
Total liabilities, Class A ordinary shares subject to redemption and shareholders' equity (deficit)	$ 415,549,536
Preference shares, par value, (per share)	$ 0.0001
As Restated | Class A Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock, par value (in dollars per share)	$ 0.0001
As Restated | Class A Ordinary Shares Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to redemption	41,400,000
As Restated | Class B Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares	$ 1,035
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total assets	415,549,535
Total liabilities	36,602,571
Class A ordinary shares subject to redemption	373,946,960
Accumulated deficit	4,998,569
Total shareholders' equity (deficit)	5,000,004
Total liabilities, Class A ordinary shares subject to redemption and shareholders' equity (deficit)	415,549,535
As Previously Reported | Class A Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares	$ 400
Common stock, shares outstanding (in shares)	4,005,304
As Previously Reported | Class A Ordinary Shares Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to redemption	37,394,696
As Previously Reported | Class B Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares	$ 1,035
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total assets	1
Class A ordinary shares subject to redemption	40,053,040
Accumulated deficit	(40,052,639)
Total shareholders' equity (deficit)	(40,053,039)
Total liabilities, Class A ordinary shares subject to redemption and shareholders' equity (deficit)	1
Adjustment | Class A Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares	$ (400)
Common stock, shares outstanding (in shares)	(4,005,304)
Adjustment | Class A Ordinary Shares Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to redemption	4,005,304

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Cash flows (Details)	6 Months Ended
	Jun. 30, 2021USD ($)
As Previously Reported
Supplemental disclosure of noncash financing activities:
Change in value of Class A ordinary shares subject to possible redemption	$ 18,038,990
Adjustment
Supplemental disclosure of noncash financing activities:
Change in value of Class A ordinary shares subject to possible redemption	$ (18,038,990)

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements - Basic and diluted earnings per share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ (2,878,827)	$ 20,917,813	$ 18,038,986
As Restated | Class A Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ (2,878,827)		$ 18,038,986
Weighted average shares outstanding	41,400,000		41,400,000
Basic and diluted loss per share	$ (0.06)		$ 0.35
As Restated | Class B Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ (2,878,827)		$ 18,038,986
Weighted average shares outstanding	10,350,000		10,350,000
Basic and diluted loss per share	$ (0.06)		$ 0.35
As Previously Reported | Class A Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ (2,878,827)		$ 18,038,986
Weighted average shares outstanding	41,400,000		41,400,000
As Previously Reported | Class B Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ (2,878,827)		$ 18,038,986
Weighted average shares outstanding	10,350,000		10,350,000
Basic and diluted loss per share	$ (0.28)		$ 1.74
Adjustment | Class A Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted loss per share	(0.06)		0.35
Adjustment | Class B Ordinary Shares
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Basic and diluted loss per share	$ 0.22		$ (1.39)

Restatement of Previously Iss_6

Restatement of Previously Issued Financial Statements - Class A Ordinary Shares Subject to Possible Redemption (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Restatement of Previously Issued Financial Statements
Gross Proceeds	$ 414,000,000
Proceeds allocated to Public Warrants	(19,458,000)
Class A ordinary shares issuance costs	(22,524,192)
Accretion of carrying value to redemption value	41,982,192
Class A ordinary shares subject to redemption	$ 414,000,000	$ 414,000,000

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (as restated) (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Cash equivalents	$ 0	$ 0
Federal depository insurance coverage	$ 250,000
Forward price	$ 10
Unrecognized tax benefits	$ 0
Unrecognized tax benefits accrued for interest and penalties	$ 0
Class B Ordinary Shares
Anti-dilutive securities attributable to warrants (in shares)	41,400,000	41,400,000
Public Warrants
Ordinary share price	$ 18
Private Placement Warrants
Number of warrants to purchase shares issued	7,386,667	7,386,667
Initial Public Offering. | Public Warrants
Number of warrants to purchase shares issued	13,800,000	13,800,000
Initial Public Offering. | Private Placement Warrants
Number of warrants to purchase shares issued	21,186,667

Initial Public Offering (Detail

Initial Public Offering (Details)	Dec. 15, 2020$ / sharesshares
Initial Public Offering.
Subsidiary, Sale of Stock [Line Items]
Number of units issued	41,400,000
Purchase price, per unit | $ / shares	$ 10
Initial Public Offering. | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit	1
Number of warrants in a unit	1
Percentage of warrant in each unit in initial public offering	0.33%
Number of redeemable warrants	1
Exercise price of warrants | $ / shares	$ 11.50
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued	5,400,000
Purchase price, per unit | $ / shares	$ 10

Private Placement (Details)

Private Placement (Details) - Private Placement Warrants - USD ($)	Dec. 15, 2020	Jun. 30, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued		7,386,667	7,386,667
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued		1.50
Private Placement.
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued	7,386,667	7,386,667
Price of warrants	$ 1.50	$ 11,080,000
Aggregate purchase price	$ 11,080,000
Number of shares per warrant		1
Exercise price of warrant		$ 11.50

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details) - Class B Ordinary Shares	Dec. 10, 2020shares	Dec. 08, 2020shares	Nov. 24, 2020shares	Oct. 02, 2020USD ($)shares	Jun. 30, 2021D$ / sharesshares	Dec. 31, 2020shares
Related Party Transaction [Line Items]
Common Stock, Shares, Issued					10,350,000	10,350,000
Common shares, shares outstanding	1,725,000				10,350,000	10,350,000
Sponsor
Related Party Transaction [Line Items]
Consideration received | $				$ 25,000
Consideration received, shares				11,500,000
Number of shares surrender			2,875,000
Sponsor Transferred Founder Shares		30,000	30,000
Share dividend	1,725,000
Common shares, shares outstanding	10,350,000
Restrictions on transfer period of time after business combination completion					1 year
Sponsor | Over-allotment option
Related Party Transaction [Line Items]
Common Stock, Shares, Issued					1,350,000
Common shares, shares outstanding					1,350,000
Shares subject to forfeiture					1,350,000
Shares no longer subject to forfeiture					0
Percentage of founder shares equal					20.00%
Founder Shares | Sponsor
Related Party Transaction [Line Items]
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares					$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D					20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D					30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences					150 days

Related Party Transactions - Re

Related Party Transactions - Related Party Loans, Promissory Note, Administrative Support Agreement (Details) - USD ($)	Dec. 16, 2020	Dec. 15, 2020	Jun. 30, 2021	Dec. 31, 2020	Oct. 01, 2020
Working capital loans warrant
Related Party Transaction [Line Items]
Loan conversion agreement warrant			$ 1,500,000
Price of warrant			$ 1.50
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note					$ 300,000
Outstanding balance of related party note				$ 130,492
Repayment of promissory note - related party	$ 130,492
Administrative Support Agreement
Related Party Transaction [Line Items]
Expenses per month		$ 10,000

Commitments and Contingencies (

Commitments and Contingencies (Details)	6 Months Ended
	Jun. 30, 2021USD ($)item$ / sharesshares
Underwriting cash discount per unit | $ / shares	$ 0.35
Aggregate underwriter cash discount | $	$ 14,490,000
Maximum number of demands for registration of securities | item	3
Over-allotment option
Period to exercise the over-allotment option	45 days
Additional units granted to underwriters to purchase | shares	14,490,000

Derivative Liabilities (Details

Derivative Liabilities (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Dec. 15, 2020
Class of Warrant or Right [Line Items]
Public Warrants expiration term	5 years
Threshold period for filling registration statement after business combination	15 days
Class A Ordinary Shares
Class of Warrant or Right [Line Items]
Maximum period after business combination in which to file registration statement	60 days
Private Placement Warrants
Class of Warrant or Right [Line Items]
Number of warrants to purchase shares issued	7,386,667	7,386,667
Public Warrants
Class of Warrant or Right [Line Items]
Warrant exercise period condition one	30 days
Warrant exercise period condition two	1 year
Period of time within which registration statement is expected to become effective	60 days
Initial Public Offering. | Private Placement Warrants
Class of Warrant or Right [Line Items]
Number of warrants to purchase shares issued	21,186,667
Number Of Forward Purchase Units	14,000,000	14,000,000
Initial Public Offering. | Public Warrants
Class of Warrant or Right [Line Items]
Number of warrants to purchase shares issued	13,800,000	13,800,000
Private Placement. | Private Placement Warrants
Class of Warrant or Right [Line Items]
Number of warrants to purchase shares issued	7,386,667		7,386,667

Derivative Liabilities - Redemp

Derivative Liabilities - Redemption of warrants (Details)	6 Months Ended
	Jun. 30, 2021D$ / shares
Class of Warrant or Right [Line Items]
Warrant redemption condition minimum share price	$ 18
Threshold issue price for capital raising purposes in connection with the closing of a Business Combination	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%
Threshold trading days for calculating Market Value | D	20
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)	100.00%
Adjustment two of redemption price of stock based on market value and newly issued price (as a percent)	180.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Warrant redemption condition minimum share price	$ 18
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Warrant redemption condition minimum share price	10
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Redemption price per public warrant (in dollars per share)	$ 0.01
Redemption period	30 days
Threshold trading days for redemption of public warrants | D	20
Threshold consecutive trading days for redemption of public warrants | D	30
Warrant redemption condition minimum share price	$ 18
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Redemption price per public warrant (in dollars per share)	$ 0.10
Redemption period	30 days
Warrant redemption condition minimum share price	$ 10

Derivative Liabilities - Forwar

Derivative Liabilities - Forward Purchase Agreement (Details)	6 Months Ended
	Jun. 30, 2021USD ($)$ / sharesshares
Class of Warrant or Right [Line Items]
Forward Purchase Per Unit | $ / shares	$ 10
Forward purchase units	14,000,000
Forward purchase amount | $	$ 140,000,000
Class A Ordinary Shares
Class of Warrant or Right [Line Items]
Number of warrants in a unit	1
Number of shares in a unit	1

Shareholders' Deficit - Preferr

Shareholders' Deficit - Preferred Stock Shares (Details) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Shareholders' Deficit
Preferred shares, shares authorized	5,000,000	5,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

Shareholders' Deficit - Common

Shareholders' Deficit - Common Stock Shares (Details)	Nov. 24, 2020shares	Dec. 08, 2020shares	Jun. 30, 2021USD ($)Vote$ / sharesshares	Mar. 31, 2021USD ($)	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 10, 2020shares
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001
Permanent equity | $			$ (35,053,035)	$ (32,174,208)	$ (53,092,021)
Temporary equity at redeemed | $			414,000,000		$ 414,000,000
Condition For Future Business Combination Threshold Net Tangible Assets | $			$ 5,000,001
Automatic Conversion Upon Business Combination Ratio Percentage			20.00%
Class A Ordinary Shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)			500,000,000		500,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001
Common shares, votes per share | Vote			1
Class A common stock subject to possible redemption, issued (in shares)			41,400,000
Class A Ordinary Shares Subject to Redemption
Class of Stock [Line Items]
Class A common stock subject to possible redemption, issued (in shares)			41,400,000
Temporary equity, shares outstanding			37,394,696
Purchase price, per unit | $ / shares					$ 10
Class A Ordinary Shares Not Subject to Redemption
Class of Stock [Line Items]
Common shares, shares authorized (in shares)			500,000,000		500,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001
Common shares, shares issued (in shares)					5,809,203
Common stock, shares outstanding (in shares)			0
Class A common stock subject to possible redemption, issued (in shares)			0		0
Temporary equity, shares outstanding			0		0
Class B Ordinary Shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)			50,000,000		50,000,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001		$ 0.0001
Common shares, votes per share | Vote			1
Common shares, shares issued (in shares)			10,350,000		10,350,000
Common stock, shares outstanding (in shares)			10,350,000		10,350,000	1,725,000
Class B Ordinary Shares | Founder Shares
Class of Stock [Line Items]
Common stock, shares outstanding (in shares)						10,350,000
Class B Ordinary Shares | Founder Shares | Sponsor
Class of Stock [Line Items]
Number of shares surrendered	2,875,000
Shares transferred		30,000
Class B Ordinary Shares | Common Stock
Class of Stock [Line Items]
Permanent equity | $			$ 1,035	$ 1,035	$ 1,035

Fair Value Measurements - Recon

Fair Value Measurements - Reconciliation of derivative liabilities (Details)	6 Months Ended
	Jun. 30, 2021USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities at beginning	$ 40,532,280
Derivative liabilities at ending	20,789,520
Public Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities at beginning	21,390,000
Change in fair value	(8,238,600)
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities at beginning	11,449,330
Change in fair value	(4,409,840)
Forward Purchase Agreement
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities at beginning	7,692,950
Change in fair value	$ (7,094,320)

Fair Value Measurements - Finan

Fair Value Measurements - Financial assets and liabilities (Details) - Recurring - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Assets:
Investments held in Trust Account	$ 414,090,409	$ 414,020,525
Liabilities:
Derivative liabilities	20,789,520	40,532,280
Public Warrants
Liabilities:
Derivative liabilities	13,151,400	21,390,000
Private Placement Warrants
Liabilities:
Derivative liabilities	7,039,490	11,449,330
Forward Purchase Agreement
Liabilities:
Derivative liabilities	598,630	7,692,950
Level 1
Assets:
Investments held in Trust Account	414,090,409	414,020,525
Liabilities:
Derivative liabilities	13,151,400
Level 1 | Public Warrants
Liabilities:
Derivative liabilities	13,151,400
Level 2
Liabilities:
Derivative liabilities	7,039,490
Level 2 | Private Placement Warrants
Liabilities:
Derivative liabilities	7,039,490
Level 3
Liabilities:
Derivative liabilities	598,630	40,532,280
Level 3 | Public Warrants
Liabilities:
Derivative liabilities		21,390,000
Level 3 | Private Placement Warrants
Liabilities:
Derivative liabilities		11,449,330
Level 3 | Forward Purchase Agreement
Liabilities:
Derivative liabilities	$ 598,630	$ 7,692,950

Fair Value Measurements - Level

Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details) - Level 3	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Share price. | Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input			10.02
Share price. | Forward
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	10.04	10.05	10.54
Exercise price | Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input			11.50
Exercise price | Forward
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	10	10	10
Term (in years) | Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input			6
Term (in years) | Forward
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0.46	0.71	0.96
Volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input			21
Risk-free interest rate | Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input			0.50
Risk-free interest rate | Forward
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0.06	0.06	0.10

Fair Value Measurements - Chang

Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Derivative liabilities at beginning		$ 40,532,280	$ 40,532,280
Derivative liabilities at ending	$ 20,789,520		20,789,520
Level 3
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Derivative liabilities at beginning	757,830	40,532,280	40,532,280
Transfers from Level 3		(32,839,330)
Change in fair value	(159,200)	(6,935,120)
Derivative liabilities at ending	$ 598,630	$ 757,830	$ 598,630

Fair Value Measurements - Addit

Fair Value Measurements - Additional information (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Fair Value Measurements
Forward price		$ 10
Warrant redemption condition minimum share price		$ 18
Change in fair value of derivative warrant liabilities	$ 1,387,420	$ (19,742,760)

Subsequent Events (Details)

Subsequent Events (Details)	Sep. 13, 2021$ / sharesshares	Jun. 30, 2021USD ($)$ / sharesshares	Dec. 31, 2020$ / shares
Subsequent Event [Line Items]
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001
Registration Rights Agreement
Subsequent Event [Line Items]
Threshold number of days to file registration statement after Closing		30 days
Public Warrants | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of warrants to purchase common stock	1
Exercise price of warrant | $ / shares	$ 11.50
Public Warrants | Merger Agreement | Subsequent Event [Member]
Subsequent Event [Line Items]
Conversion ratio	1
Number of warrants converted to Domesticated Company Common Stock	1
Private Placement Warrants | Merger Agreement | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of warrants converted to Domesticated Company Common Stock	1
PIPE Investors | Subscription Agreement
Subsequent Event [Line Items]
Number of shares issued		6.85
Share price | $ / shares		$ 10
Aggregate purchase price | $		$ 68,500,000
Forge | Merger Agreement
Subsequent Event [Line Items]
Threshold percentage of consideration payable in cash		15.00%
Threshold amount of consideration payable in cash | $		$ 100,000,000
Aggregate value of consideration transferred | $		$ 1,500,000,000
Number of shares issuable		140,000,000
Deemed value per share | $ / shares		$ 10
Class A Ordinary Shares
Subsequent Event [Line Items]
Common stock, par value (in dollars per share) | $ / shares		0.0001	$ 0.0001
Class A Ordinary Shares | Merger Agreement | Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001
Class B Ordinary Shares
Subsequent Event [Line Items]
Common stock, par value (in dollars per share) | $ / shares		0.0001	$ 0.0001
Class B Ordinary Shares | Merger Agreement | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares converted to Domesticated Company Common Stock	1
Forward Purchase Units [Member] | Merger Agreement | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of warrants converted to Domesticated Company Common Stock	0.33
Number of shares in a unit converted to Domesticated Company Common Stock	1
Forward Purchase Units [Member] | Forward Purchase Agreement
Subsequent Event [Line Items]
Unit price | $ / shares		$ 10
Number of maximum units can be sold to purchasers		5,000,000
Additional forward purchase units		9,000,000
Maximum amount of units that can be sold to purchasers | $		$ 14,000,000